title: Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry.
authors.forename: Amy Leigh
authors.initials: AL
authors.lastname: Miller
authors.forename: Yongfei
authors.initials: Y
authors.lastname: Wang
authors.forename: Jeptha
authors.initials: J
authors.lastname: Curtis
authors.forename: Frederick A
authors.initials: FA
authors.lastname: Masoudi
authors.forename: Alfred E
authors.initials: AE
authors.lastname: Buxton
authors.forename: Tracy Y
authors.initials: TY
authors.lastname: Wang
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D017147:Defibrillators, Implantable; D019983:Guideline Adherence / Q000706:statistics & numerical data*; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D012042:Registries
chemical_list: D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors